{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:44:01Z","timestamp":1792079041736,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.modpat.2026.101082","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:25:18Z","timestamp":1788823518000},"page":"101082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary Cutaneous Apocrine Carcinoma: Clinicopathologic, Immunohistochemical, and Molecular Characterization of 27 Cases"],"prefix":"10.1016","volume":"39","author":[{"given":"Jakob M.T.","family":"Moran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen T.","family":"Shore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Dias-Santagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro C.","family":"Laga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Hosler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Mochel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1406-7981","authenticated-orcid":false,"given":"Mai P.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2026.101082_bib1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181590ba4","article-title":"Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases","volume":"32","author":"Robson","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/1097-0142(19930115)71:2<375::AID-CNCR2820710218>3.0.CO;2-4","article-title":"Apocrine carcinoma of the skin. A clinicopathologic, immunocytochemical, and ultrastructural study","volume":"71","author":"Paties","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.modpat.2026.101082_bib3","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1111\/ajd.13199","article-title":"A clinical, pathological and immunohistochemical series of 9 cases of primary cutaneous apocrine carcinomas of the head and neck","volume":"61","author":"Portelli","year":"2020","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.modpat.2026.101082_bib4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/his.14436","article-title":"Signet-ring cell\/histiocytoid carcinoma of the axilla: a clinicopathological and genetic analysis of 11 cases, review of the literature, and comparison with potentially related tumours","volume":"79","author":"Goto","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2026.101082_bib5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/jjco\/hyae103","article-title":"A review of cutaneous apocrine carcinoma: epidemiology, diagnosis, prognosis, and treatment options","volume":"54","author":"Tsuruta","year":"2024","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.modpat.2026.101082_bib6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.humpath.2013.09.007","article-title":"Cutaneous and mammary apocrine carcinomas have different immunoprofiles","volume":"45","author":"Piris","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/cup.14588","article-title":"PIK3CA mutation status in apocrine carcinoma arising in apocrine gland hyperplasia\/apocrine nevus: a study of four cases","volume":"51","author":"Goto","year":"2024","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib8","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1038\/s41379-020-0589-x","article-title":"Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas","volume":"33","author":"Sun","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jaad.2025.05.004","article-title":"Carcinoma en cuirasse is an independent poor survival predictor in breast carcinoma patients with cutaneous metastasis","volume":"93","author":"Chen","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.modpat.2026.101082_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdcr.2024.04.025","article-title":"Exome sequencing reveals biallelic inactivation of KMT2C in cutaneous apocrine carcinoma: a case report and review of the literature","volume":"49","author":"Hirano-Lotman","year":"2024","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.modpat.2026.101082_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/cup.14607","article-title":"Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion","volume":"51","author":"Lenskaya","year":"2024","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/cup.13733","article-title":"Molecular profiling of a primary cutaneous signet-ring cell\/histiocytoid carcinoma of the eyelid","volume":"47","author":"Raghavan","year":"2020","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2019.08.023","article-title":"Deep and sustained radiological response after MEK-RAF inhibition in HRAS mutant apocrine carcinoma of the scalp","volume":"122","author":"Scaranti","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.modpat.2026.101082_bib14","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/cup.14085","article-title":"Independent primary cutaneous and mammary apocrine carcinomas with neuroendocrine differentiation: report of a case and literature review","volume":"48","author":"DeCoste","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jdcr.2017.03.006","article-title":"Metastatic cutaneous apocrine carcinoma: multidisciplinary approach achieving complete response with adjuvant chemoradiation","volume":"3","author":"Hibler","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.modpat.2026.101082_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/cup.14539","article-title":"Apocrine carcinoma with marked sebocyte-like cytological features: a report of two cases","volume":"51","author":"Sasaki-Saito","year":"2024","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib17","article-title":"Favorable response to combined androgen blockade for metastatic cutaneous apocrine carcinoma: a case report","volume":"5","author":"Imajima","year":"2020","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.modpat.2026.101082_bib18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.18632\/oncotarget.27961","article-title":"Ex vivo analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma","volume":"12","author":"M\u00e4kel\u00e4","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.modpat.2026.101082_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/cup.13838","article-title":"Signet-ring cell\/histiocytoid carcinoma in the axilla: a case report with genetic analysis using next-generation sequencing","volume":"48","author":"Ito","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib20","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/modpathol.2011.48","article-title":"A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas","volume":"24","author":"Dias-Santagata","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047290","article-title":"Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses","volume":"7","author":"Le","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.modpat.2026.101082_bib22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.5858\/arpa.2023-0950-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer","volume":"147","author":"Wolff","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.modpat.2026.101082_bib23","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.modpat.2026.101082_bib24","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.modpat.2026.101082_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1158\/2159-8290.CD-23-0467","article-title":"Quantifying the expanding landscape of clinical actionability for patients with cancer","volume":"14","author":"Suehnholz","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.modpat.2026.101082_bib26","article-title":"A precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.modpat.2026.101082_bib27","series-title":"R: a language and environment for statistical computing","year":"2026"},{"key":"10.1016\/j.modpat.2026.101082_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/PAS.0000000000002073","article-title":"Triple-negative breast carcinoma with apocrine and histiocytoid features: a clinicopathologic and molecular study of 18 cases","volume":"47","author":"Wang","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib29","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s12276-023-01030-z","article-title":"Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.modpat.2026.101082_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100125","article-title":"Triple-negative apocrine carcinomas: toward a unified group with shared molecular features and clinical behavior","volume":"36","author":"Schwartz","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jso.22023","article-title":"Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm","volume":"105","author":"Hollowell","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.modpat.2026.101082_bib32","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/DSS.0000000000004633","article-title":"Incidence, tumor characteristics, and survival of patients with cutaneous apocrine carcinoma: a retrospective study of 323 patients in the Surveillance, Epidemiology, and End Results program","volume":"51","author":"Joshi","year":"2025","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.modpat.2026.101082_bib33","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1097\/DAD.0000000000000810","article-title":"Cutaneous apocrine carcinoma with an in situ component and histiocytoid and signet-ring cells","volume":"39","author":"Berdugo","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.modpat.2026.101082_bib34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0344-0338(97)80031-3","article-title":"Apocrine carcinoma with signet ring cells and histiocytoid features. A potentially confusing axillary tumor","volume":"193","author":"Cameselle-Teijeiro","year":"1997","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.modpat.2026.101082_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00000372-199608000-00010","article-title":"Epidermotropically metastatic breast carcinomas. Rare histopathologic variants mimicking melanoma and Paget\u2019s disease","volume":"18","author":"Requena","year":"1996","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.modpat.2026.101082_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/DAD.0000000000001841","article-title":"Histologic patterns of cutaneous metastases of breast carcinoma: a clinicopathologic study of 232 cases","volume":"43","author":"Ronen","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.modpat.2026.101082_bib37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/onc.2012.53","article-title":"Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations","volume":"32","author":"Yuan","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.modpat.2026.101082_bib38","doi-asserted-by":"crossref","first-page":"14372","DOI":"10.1073\/pnas.1303204110","article-title":"Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies","volume":"110","author":"Hanker","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.modpat.2026.101082_bib39","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nm.2402","article-title":"Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms","volume":"17","author":"Liu","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.modpat.2026.101082_bib40","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1158\/0008-5472.CAN-10-0738","article-title":"Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation","volume":"71","author":"Adams","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.modpat.2026.101082_bib41","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nm.1890","article-title":"Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers","volume":"14","author":"Engelman","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.modpat.2026.101082_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/1078-0432.CCR-16-0134","article-title":"A phase Ib study of alpelisib (BYL719), a PI3K\u03b1-specific inhibitor, with letrozole in ER+\/HER2- metastatic breast cancer","volume":"23","author":"Mayer","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101082_bib43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2018.01.021","article-title":"Systematic functional annotation of somatic mutations in cancer","volume":"33","author":"Ng","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2026.101082_bib44","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1073\/pnas.1205508109","article-title":"Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110\u03b1 (PIK3CA)","volume":"109","author":"Burke","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.modpat.2026.101082_bib45","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1038\/onc.2011.532","article-title":"Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases","volume":"31","author":"Hon","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.modpat.2026.101082_bib46","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1073\/pnas.0701005104","article-title":"Rare cancer-specific mutations in PIK3CA show gain of function","volume":"104","author":"Gymnopoulos","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.modpat.2026.101082_bib47","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1158\/1078-0432.CCR-22-2115","article-title":"Biology and targetability of the extended spectrum of PIK3CA mutations detected in breast carcinoma","volume":"29","author":"Rugo","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101082_bib48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Carpten","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.101082_bib49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4161\/cc.7.5.5485","article-title":"Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung","volume":"7","author":"Malanga","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.modpat.2026.101082_bib50","doi-asserted-by":"crossref","first-page":"19368","DOI":"10.1073\/pnas.1204384109","article-title":"Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancers","volume":"109","author":"Parikh","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.modpat.2026.101082_bib51","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1200\/JCO.2017.73.0143","article-title":"AKT inhibition in solid tumors with AKT1 mutations","volume":"35","author":"Hyman","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.modpat.2026.101082_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026760","article-title":"Differential sensitivity of ERBB2 kinase domain mutations towards lapatinib","volume":"6","author":"Kancha","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.modpat.2026.101082_bib53","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/2159-8290.CD-12-0349","article-title":"Activating HER2 mutations in HER2 gene amplification negative breast cancer","volume":"3","author":"Bose","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.modpat.2026.101082_bib54","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1158\/1078-0432.CCR-18-0991","article-title":"High-throughput functional evaluation of variants of unknown significance in ERBB2","volume":"24","author":"Nagano","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101082_bib55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41588-018-0287-5","article-title":"Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapies","volume":"51","author":"Nayar","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.modpat.2026.101082_bib56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/1078-0432.CCR-18-1544","article-title":"Combined blockade of activating ERBB2 mutations and ER results in synthetic lethality of ER+\/HER2 mutant breast cancer","volume":"25","author":"Croessmann","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"7691","key":"10.1016\/j.modpat.2026.101082_bib57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature25475","article-title":"HER kinase inhibition in patients with HER2- and HER3-mutant cancers","volume":"554","author":"Hyman","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.101082_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2025.111118","article-title":"High-throughput characterization of 5886 HER2 variants identifies 112 new in cellulo gain-of-function mutations","volume":"117","author":"Giacoletto","year":"2025","journal-title":"Genomics"},{"key":"10.1016\/j.modpat.2026.101082_bib59","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/1078-0432.CCR-07-4367","article-title":"EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation","volume":"14","author":"Trowe","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101082_bib60","doi-asserted-by":"crossref","first-page":"14476","DOI":"10.1073\/pnas.1203201109","article-title":"Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2","volume":"109","author":"Greulich","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.modpat.2026.101082_bib61","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1074\/jbc.M708116200","article-title":"Mutational activation of ErbB2 reveals a new protein kinase autoinhibition mechanism","volume":"283","author":"Fan","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.modpat.2026.101082_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2006.05.023","article-title":"HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors","volume":"10","author":"Wang","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2026.101082_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.986674","article-title":"Molecular and clinicopathological characteristics of ERBB2 gene fusions in 32,131 Chinese patients with solid tumors","volume":"12","author":"Guan","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.modpat.2026.101082_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1115405","article-title":"ERBB family fusions are recurrent and actionable oncogenic targets across cancer types","volume":"13","author":"Schubert","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.modpat.2026.101082_bib65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.101082_bib66","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41388-026-03699-8","article-title":"Association of retinoids, retinoic acid receptors and epigenetics in breast cancer","volume":"45","author":"Szyma\u0144ski","year":"2026","journal-title":"Oncogene"},{"key":"10.1016\/j.modpat.2026.101082_bib67","doi-asserted-by":"crossref","DOI":"10.1200\/PO-26-00037","article-title":"Genomics of MTAP loss in >500,000 solid tumor specimens profiled using comprehensive genomic profiling platforms","volume":"10","author":"Pavlick","year":"2026","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.modpat.2026.101082_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262411956","article-title":"MTAP deletion as a therapeutic vulnerability in cancer: from molecular mechanism to clinical targeting","volume":"26","author":"Krawczyk","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.modpat.2026.101082_bib69","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3390\/ijms25031817","article-title":"Treatments targeting the androgen receptor and its splice variants in breast cancer","volume":"25","author":"Tien","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.modpat.2026.101082_bib70","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1186\/s12885-024-13165-x","article-title":"Prognostic role of androgen receptor splice variant 7 (AR-V7) in the pathogenesis of breast cancer","volume":"24","author":"Srivastava","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.modpat.2026.101082_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clgc.2019.09.015","article-title":"Androgen receptor splice variant, AR-V7, as a biomarker of resistance to androgen axis-targeted therapies in advanced prostate cancer","volume":"18","author":"Zhang","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.modpat.2026.101082_bib72","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41379-021-00924-5","article-title":"Androgen receptor splice variant-7 in breast cancer: clinical and pathologic correlations","volume":"35","author":"Ferguson","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.101082_bib73","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1002\/ccr3.3434","article-title":"Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti-androgen therapy\u2014a case report","volume":"8","author":"Collette","year":"2020","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.modpat.2026.101082_bib74","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/jpm12020261","article-title":"Androgen receptor: a new marker to predict pathological complete response in HER2-positive breast cancer patients treated with trastuzumab plus pertuzumab neoadjuvant therapy","volume":"12","author":"Li","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.modpat.2026.101082_bib75","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s13691-024-00700-7","article-title":"Treatment of HER2-positive cutaneous apocrine carcinoma of the axilla","volume":"13","author":"Kamata","year":"2024","journal-title":"Int Cancer Conf J"},{"key":"10.1016\/j.modpat.2026.101082_bib76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/BD-201027","article-title":"Primary ectopic breast carcinoma in the axilla: a rare presentation and review of the literature","volume":"40","author":"Salemis","year":"2021","journal-title":"Breast Dis"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:45:54Z","timestamp":1792075554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226001250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0893395226001250"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101082","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Cutaneous Apocrine Carcinoma: Clinicopathologic, Immunohistochemical, and Molecular Characterization of 27 Cases","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101082"}}